Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aquaray is an ophthalmic lubricant formulation containing carboxymethylcellulose (also known as carmellose), developed by Raymed. It is used as artificial tears to provide temporary relief from burning, irritation, and discomfort caused by dry eye syndrome or environmental factors such as wind, sun, and prolonged screen exposure. Carboxymethylcellulose acts by stabilizing the tear film and maintaining necessary lubrication on the ocular surface, mimicking the behavior of natural tears.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carboxymethylcellulose.